These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23737589)

  • 61. Late reactivation of thyroid orbitopathy.
    Selva D; Chen C; King G
    Clin Exp Ophthalmol; 2004 Feb; 32(1):46-50. PubMed ID: 14746591
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Thyroid-associated ophthalmopathy].
    Kloster R; Elverland HH; Pierre-Jerome C; Trumpy JH
    Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2332-4. PubMed ID: 9691800
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.
    Boschi A; Daumerie Ch; Spiritus M; Beguin C; Senou M; Yuksel D; Duplicy M; Costagliola S; Ludgate M; Many MC
    Br J Ophthalmol; 2005 Jun; 89(6):724-9. PubMed ID: 15923509
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endoscopic orbital decompression for thyroid eye disease.
    Asaria RH; Koay B; Elston JS; Bates GE
    Eye (Lond); 1998; 12 ( Pt 6)():990-5. PubMed ID: 10326002
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Orbital decompression in Graves' orbitopathy: efficacy and safety.
    Goh MS; McNab AA
    Intern Med J; 2005 Oct; 35(10):586-91. PubMed ID: 16207257
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dysthyroid optic neuropathy without extraocular muscle involvement.
    Anderson RL; Tweeten JP; Patrinely JR; Garland PE; Thiese SM
    Ophthalmic Surg; 1989 Aug; 20(8):568-74. PubMed ID: 2779967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IgG4-related ocular adnexal disease mimicking thyroid-associated orbitopathy.
    Inaba H; Hayakawa T; Miyamoto W; Takeshima K; Yamaoka H; Furukawa Y; Kawashima H; Ariyasu H; Wakasaki H; Furuta H; Nishi M; Nakao T; Sasaki H; Okada Y; Matsunaga K; Nakamura Y; Akamizu T
    Intern Med; 2013; 52(22):2545-51. PubMed ID: 24240795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Orbital decompression for non-Graves' orbitopathy: a consideration of extended indications for decompression.
    Goldberg RA; Hwang MM; Garbutt MV; Shorr N
    Ophthalmic Plast Reconstr Surg; 1995 Dec; 11(4):245-52; discussion 253. PubMed ID: 8746815
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Graves' orbitopathy and restrictive myopathy.
    Biedner B; Marcus M; Yassur Y
    Thyroidology; 1991 May; 3(2):79-83. PubMed ID: 1726905
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The importance of keeping the chin up in graves orbitopathy.
    Renier S; Spileers W; Mombaerts I
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):484-6. PubMed ID: 20700077
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Common eyelid and orbital problems.
    Lissner GS
    Postgrad Med; 1985 Dec; 78(8):121-33. PubMed ID: 3840890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Value of MRI in the treatment of Grave's disease orbital myopathy].
    Oğuz V; Yolar M; Yetik H; Cakirer D; Uysal O; Pazarli H
    J Fr Ophtalmol; 2001 Oct; 24(8):842-6. PubMed ID: 11894535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Surgical treatment of proptosis bulbi by three-wall orbital decompression.
    van der Wal KG; de Visscher JG; Boukes RJ; Smeding B
    J Oral Maxillofac Surg; 1995 Feb; 53(2):140-2; discussion 143. PubMed ID: 7830178
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Successful treatment of hypothyroid Graves' disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit.
    Koshiyama H; Mori S; Fujiwara K; Hayakawa K; Koh T
    Intern Med; 1993 May; 32(5):421-3. PubMed ID: 8400507
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dysthyroid orbitopathy.
    Jacobson DM
    Semin Neurol; 2000; 20(1):43-54. PubMed ID: 10874776
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reactivation of thyroid-associated orbitopathy after cataract surgery.
    Shadpour JM; Menghani RM; Douglas RS; Goldberg RA; Tsirbas A
    Jpn J Ophthalmol; 2009 Jan; 53(1):44-46. PubMed ID: 19184309
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Orbital apex lesion as the presenting manifestation of sarcoidosis.
    Segal EI; Tang RA; Lee AG; Roberts DL; Campbell GA
    J Neuroophthalmol; 2000 Sep; 20(3):156-8. PubMed ID: 11001189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.